Orthobiologics and Chiropractic for Joint Healing Insights

Orthobiologics and Chiropractic for Joint Healing: An Evidence-Based Clinical Journey With PRP, Tendon Healing, and Osteoarthritis Management

Abstract

In this educational post, I present a clear, first-person clinical roadmap for using platelet-rich plasma (PRP) and related orthobiologic strategies to treat partial-thickness tendon tears, shoulder and knee osteoarthritis, enthesopathies, and overuse injuries. I lay out the practical criteria we use to identify appropriate candidates, explain how imaging guides precise percutaneous interventions, and detail a stepwise algorithm for knee osteoarthritis that integrates biology, biomechanics, and patient-specific risk factors. I also unpack the physiological mechanisms of tendon and cartilage healing, why certain injuries respond better to biologics than others, and how machine learning and lab biomarkers may help predict PRP responders. Along the way, I describe how we integrate chiropractic care, functional medicine, rehabilitation, and personal injury management in a multidisciplinary model under the medical direction of Dr. Maria Guadalupe Cardenas, MD, who collaborates with me at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. This model brings together modern, evidence-based research and hands-on care to deliver precise, personalized treatment plans that prioritize outcomes, safety, and long-term function.

Introducing Our Multidisciplinary Team and Care Model

I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Over the past decade, I have focused on integrating chiropractic medicine, functional medicine, regenerative and orthobiologic strategies, and structured rehabilitation within coordinated personal injury and musculoskeletal care. My clinical insights, shared regularly on WellnessDoctorRx and through professional reports, emphasize measurable outcomes, imaging-informed decisions, and patient-centered protocols tailored to biological and mechanical realities of healing.

• New medical leadership and collaboration:
  • I am honored to announce that Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933), with over 40 years of experience as an internist, has joined our team as Medical Director and Collaborative Physician in El Paso, Texas.
  • In our integrative setup, Dr. Cardenas provides medical oversight, optimizes internal medicine considerations (metabolic health, cardiometabolic risk, endocrine status, comorbidities), and co-manages cases where medical risk, medication considerations, or complex diagnostics intersect with musculoskeletal care.
  • I coordinate chiropractic and rehabilitation services, percutaneous procedures in the musculoskeletal scope, and functional medicine protocols, aligning hands-on biomechanics with biologic recovery.
• How we integrate disciplines:
  • Chiropractic care: targeted spinal and extremity adjustments, joint mobilization, soft-tissue release, biomechanical corrections, and kinetic chain optimization.
  • Internal medicine oversight: risk stratification, medication review, differential diagnosis, lab and imaging coordination, and medical co-management for complex cases.
  • Functional medicine: gut-joint axis evaluation, inflammation modulation, nutrient sufficiency, mitochondrial support, sleep optimization, and behavior change.
  • Orthobiologics: PRP for tendinopathy and osteoarthritis; consideration of microfragmented adipose tissue in advanced cases; and percutaneous tenotomy for calcific tendinitis.
  • Rehabilitation: phased loading, motor control retraining, eccentric and isometric prescriptions, tendon-specific protocols, and progressive return-to-sport or work.
  • Personal injury care: documentation, causation analysis, work-related injury coordination, and functional restoration.

This model reflects a common and effective structure in integrative and injury care clinics, where an MD provides medical direction alongside a chiropractor. It allows us to blend advanced, evidence-based methods with close monitoring of systemic health and rehabilitation milestones for safer, more precise outcomes.

Evidence-Driven Orthobiologics: Who Benefits and Why

When I began practicing in El Paso, TX, many of my patients were highly educated professionals and clinicians. That environment sharpened my insistence on applying modern, evidence-based methods and treating strictly within conditions supported by reasonable-quality studies. Working with orthopedic partners, we agreed on specific cohorts most likely to benefit from biologic interventions such as PRP. These include:

• Shoulder:
  • Low-grade partial-thickness rotator cuff tears
  • Mild-to-moderate glenohumeral osteoarthritis
  • Consideration of acromiohumeral alignment using the Walch classification to ensure the “golf ball” (humeral head) is not “falling off the tee,” preserving mechanics
• Elbow and wrist/hand:
  • Lateral epicondylopathy (tennis elbow) and medial epicondylopathy (golfer’s elbow)
  • Proximal partial UCL sprains (selected cases)
  • Mild-to-moderate first carpometacarpal (CMC) osteoarthritis
• Hip and pelvis:
  • Femoroacetabular impingement (FAI) grade 2 or less with intact labral structural integrity
  • Gluteus medius tendinopathy
  • Proximal hamstring tendinopathy (mid-portion lesions, especially focal tears, tend to respond better)
• Foot and ankle:
  • Plantar fasciitis and related fascial enthesopathies
• Knee:
  • Mild-to-moderate osteoarthritis
  • Small, stable meniscal lesions
  • Select postoperative settings where PRP is added after rotator cuff repair in the 0–6 week period in coordination with the surgeon’s protocol

Why these indications? The physiology of tendon and joint healing helps explain the pattern.

• Tendon and enthesis biology:
  • Partial-thickness tears preserve some collagen architecture and vascularity. PRP’s growth factors (e.g., PDGF, TGF-β, VEGF) can stimulate tenocyte proliferation, collagen type I synthesis, and neovascular remodeling, particularly in mechanically favorable environments.
  • Microtrauma-driven degeneration (tendinosis) features disorganized collagen, neovascularity, and altered ECM; biologics plus graded load can reorient collagen and restore tensile properties.
  • Full-thickness tears have discontinuity and retraction; orthobiologics alone rarely reapproximate tissue integrity. Surgery or scaffold-based solutions may be necessary.
• Cartilage and subchondral unit:
  • Osteoarthritis is not only cartilage thinning; it reflects synovial inflammation, subchondral bone marrow lesions, and altered mechanobiology. PRP reduces synovitis, modulates catabolic cytokines, and may improve cartilage homeostasis in milder disease states.
  • In higher-grade OA, additional strategies (e.g., bone-focused approaches or scaffold-based adjuncts) may be necessary due to compromised joint unit biology.

These physiological insights, supported by growing literature, guide our case selection and set realistic expectations for patients.

Imaging-Guided Precision: Treating the Whole Lesion

As a clinician, I find that precise, ultrasound-guided needle placement and lesion-mapped injections matter. On ultrasound, I evaluate:

• Short- and long-axis views of tendons to capture the full length and width of partial tears
• Echotexture heterogeneity indicating tendinosis
• Calcific deposits requiring targeted tenotomy or lavage
• Bursal planes and fascial layers for hydrodissection when needed

A key technical pearl that has improved my outcomes: I systematically track the full length and width of a partial tear and distribute biologic treatment across its entirety rather than “spot-injecting” a single point. Using small volumes of fluid to delineate the lesion’s extent enhances accuracy and ensures that the biologic contacts the true degenerative matrix.

Clinical example:

• Patellar tendinopathy in a 31-year-old weightlifter with coexisting knee OA, a significant partial-thickness patellar tendon tear, and a calcific focus. The clinical decision hinges on source-of-pain analysis:
  • Articular pain from cartilage vs enthesis pain from the tendon
  • Palpation tenderness, load-provoked pain, and functional tests, combined with ultrasound, guided a tendon-focused PRP plan, with later consideration of joint-directed care if symptoms persisted.

Rationale:

• If the predominant nociception localizes to the tendon and the imaging shows a focal partial tear, targeted PRP and a tendon-specific loading program address the primary pain generator, while joint OA is managed with unloading, anti-inflammatory strategies, and—if needed—staged PRP intra-articularly.

Rotator Cuff Partial Tears: A Multi-Target Strategy

For partial-thickness rotator cuff tears, I prioritize:

• Lesion mapping: differentiate interstitial versus bursal- or articular-sided tears.
• Edema and interstitial signal: on fluid-sensitive MRI, edema indicates inflammatory activity and microinstability; we consider addressing both the interstitial defect and adjacent inflamed tissue planes.
• Injection strategy: in select cases, I perform two to three small-volume injections to encompass the tear margins and associated reactive zones, improving biologic coverage.

Why treat both interstitial injury and edema zones?

• The local biochemical milieu (elevated IL-1β, TNF-α, MMPs) and shear forces perpetuate degeneration. Addressing the interstitial tear while modulating adjacent inflammatory tissues may tip the balance toward matrix reconstitution and improved gliding mechanics.

Important distinctions:

• Partial-thickness (≤50% depth) vs full-thickness
• Partial-width vs full-width tears
• These distinctions influence the probability of healing and the appropriateness of orthobiologics. Orthobiologics are more effective in partial-thickness, partial-width tears with preserved continuity and tension-sharing capacity.

When I Consider Microfragmented Adipose Tissue

In higher-grade partial-thickness tears (depth greater than 50%) or moderate OA, where scaffolding and paracrine support may be advantageous, I may consider microfragmented adipose tissue under appropriate medical oversight. The rationale includes:

• Scaffold effect: adipose-derived stromal vascular fraction components provide extracellular matrix and cytokine support to help maintain biologic activity at the lesion site.
• Synovial modulation: in osteoarthritic joints, adipose-derived factors may reduce synovitis and improve pain/function outcomes when PRP alone is insufficient.

My practical approach:

• Low-grade partial tears: PRP or PRP plus adjunctive hydrodissection/P2G where indicated.
• Higher-grade partial tears or moderate OA not responding to PRP: consider adipose-based options, ensuring patient selection based on imaging, comorbidity profile, and functional goals.

Knee Osteoarthritis: A Stepwise Algorithm That Integrates Biology and Biomechanics

I follow a pragmatic algorithm when treating knee osteoarthritis. The steps:

1. Screen for systemic disease and poor-healing states:
   • Endocrine issues (thyroid, sex hormones), metabolic syndrome, hyperuricemia, anemia, micronutrient deficits, chronic inflammatory states.
   • Microbiome and gut-joint considerations when symptom patterns or history suggest dysbiosis or food-driven inflammation.
2. Grade osteoarthritis severity:
   • Mild-to-moderate OA: PRP is first-line biologic therapy in many cases, combined with cartilage-protective loading and anti-inflammatory functional medicine strategies.
   • Grade 3–4 OA with significant structural compromise: consider scaffold-supportive strategies or referral for definitive surgical consultation, depending on goals and function.
3. Assess subchondral bone marrow lesions (BMLs) on MRI:
   • BMLs often correlate with pain and mechanical overload. If present, PRP alone may be insufficient; adjunctive strategies or staged care may be required.
4. Set expectations with a timed response window:
   • Expected PRP course: transient increased pain for about 3 days; early gains around 3–6 weeks; clearer trajectory by 12 weeks.
   • Decision point: if not 60% improved by 12 weeks, we reassess load patterns and systemic factors and consider alternative or adjunctive biologics.

Why PRP in mild-to-moderate OA?

• PRP reduces synovial inflammation, improves HA synthesis, counters catabolic signaling, and may improve cartilage symptomatology and function more than saline or some HA preparations in selected patients. The degree of structural damage and presence of BMLs modulate response.

Machine Learning and Predicting PRP Responders

Emerging research using machine learning has begun to identify baseline factors that predict PRP response in osteoarthritis. In a recent study from China, models integrating anthropometric and laboratory markers improved the identification of high responders. Notably:

• Joint osmotic pressure (swelling/effusion)
• Lipoprotein(a)
• Uric acid

were among variables associated with differential outcomes, along with baseline pain and functional scores.

Clinical meaning:

• Elevated synovial fluid load and recurrent effusions often correlate with poorer PRP response unless inflammation is addressed first.
• Hyperuricemia and lipid anomalies may reflect systemic inflammatory tone, oxidative stress, and microvascular impacts that affect joint healing capacity.

What we do with this insight:

• Under Dr. Cardenas’ internal medicine oversight, we:
  • Check uric acid and lipid profiles, including Lp(a) when indicated.
  • Address metabolic and inflammatory drivers prior to or alongside PRP.
  • Combine joint unloading and edema management (compression, lymphatic techniques, activity titration) with biologics to improve the synovial environment.

This is a practical example of how precision medicine and integrative care improve the odds of a meaningful, durable response.

The Role of Integrative Chiropractic Care in Orthobiologic Recovery

Chiropractic care is not an isolated modality in our clinic; it is integrated from the start because mechanics drive biology. My clinical observations across years of practice, echoed in my published insights, show that correcting dysfunctional joint mechanics and soft-tissue loading improves the local biological milieu and the effectiveness of PRP and related therapies.

• Why chiropractic adjustments and mobilization matter:
  • Restoring joint play and segmental motion reduces aberrant shear on tendons and entheses.
  • Improved kinetic chain alignment decreases focal overload on degenerating tissues.
  • Neural input from spinal manipulation may modulate central pain processing and muscle activation patterns, supporting better rehabilitation fidelity.
• Soft tissue and fascial work:
  • Myofascial release and instrument-assisted techniques reduce nociceptive input from trigger points and densified fascia, which otherwise perpetuate protective guarding and altered movement.
  • In the shoulder, releasing the posterior capsule and pectoralis minor can normalize scapulothoracic mechanics, thereby reducing rotator cuff impingement forces.
• Tendon-specific loading:
  • Eccentric and heavy slow resistance (HSR) programs stimulate tendon remodeling, promote collagen I synthesis, and normalize tendon stiffness. Pairing a PRP injection with a phased HSR protocol improves structural and functional gains.
  • Isometrics provide early-stage analgesia, enabling earlier re-engagement with movement while protecting the healing lesion.
• Gait and kinetic chain:
  • In knee OA and patellar tendinopathy, addressing hip abductor strength and foot mechanics changes patellofemoral kinematics and tibiofemoral load distribution.
  • Orthotic assessment and targeted hip-core integration reduce recurrent strain at the patellar tendon and joint line.

In short, biologics supply the biochemical stimulus; chiropractic and rehabilitation organize the mechanical environment to translate that stimulus into durable tissue quality.

Ultrasound-Guided Technique Pearls That Improve Outcomes

My technique emphasizes fully characterizing the lesion, then optimizing needle trajectory and distribution:

• Map the tear:
  • Evaluate in short and long axis to identify the full geometry (length, width, depth).
  • Identify interstitial fluid clefts; note any bursal or articular side communication.
  • Assess adjacent bursa, peritendinous fat, and fascial compartments.
• Plan the approach:
  • Use hydrodissection to safely reach deeper fascial planes or separate sensitive structures (e.g., subacromial-subdeltoid bursa).
  • For calcific tendinitis, percutaneous tenotomy and lavage may be performed to reduce pain generators and allow biologic integration into a cleaner tendon bed.
• Distribute the biologic:
  • Deliver small boluses along the tear’s full extent; avoid pooling in one region.
  • If edema zones are major drivers, consider limited adjunctive deposition to modulate the local inflammatory state.
• Post-procedure phases:
  • Analgesic protection without NSAIDs (to avoid impairing platelet activity and early healing signals).
  • Staged loading: isometrics → eccentrics/HSR → plyometrics/return to sport.
  • Swelling control, sleep optimization, and anti-inflammatory nutrition support.

These principles apply to elbow, patellar tendon, and gluteal tendinopathies, as well as rotator cuff tendinopathy, with anatomical modifications.

Biomechanics of the Rotator Cable and Injection Considerations

Clinical observation and biomechanical studies show that the rotator cable—a thickened band of fibers—redistributes forces across the cuff. Tears adjacent to the rotator cable, particularly anterosuperiorly near the biceps tendon, live in a challenging mechanical environment:

• Higher shear and translational forces
• Greater motion from biceps loading
• Potential dispersion of injectate away from the lesion site

My clinical takeaways:

• Tears farther from the bicipital groove sometimes have better localization of biologic material and more stable early healing.
• In cable-adjacent tears, I may increase mechanical protection during early rehab (scapular control, deloaded ranges, careful isometric progressions) to allow biology to establish itself before subjecting the area to complex motion patterns.

Functional Medicine and Internal Medicine Oversight: Optimizing the Healing Terrain

Healing is systemic. Under Dr. Cardenas’ medical direction, we integrate internal and functional medicine to optimize the patient’s terrain:

• Inflammatory tone:
  • Assess hs-CRP, uric acid, and, when appropriate, Lp(a).
  • Dietary strategies: Mediterranean-style patterns, polyphenol-rich foods, omega-3 optimization, controlled glycemic load.
  • Consider vitamin D sufficiency, magnesium status, and collagen-building cofactors (vitamin C).
• Endocrine balance:
  • Thyroid function, sex hormones in midlife adults, and insulin resistance screening inform the potential for tissue remodeling.
• Microbiome considerations:
  • GI symptoms, antibiotic history, or an autoimmune context may prompt a gut evaluation; a healthier gut barrier reduces the systemic inflammatory burden affecting joints and tendons.
• Sleep and stress:
  • Growth hormone and collagen synthesis peak during deep sleep; we coach strategies for sleep hygiene and circadian regularity to fortify tissue repair.

These elements personalize care and align with the emerging data that systemic biomarkers influence PRP outcomes.

Personal Injury and Work-Related Cases: Coordinated Recovery

In injury and occupational cases, mechanical loading, timelines, and documentation are essential. We:

• Precisely define the source of pain with imaging, exam, and functional tests.
• Stage care: acute protection, subacute remodeling, and gradual reintegration into job-specific movements.
• Use outcome measures (e.g., pain scales, KOOS/LEFS/DASH), return-to-duty metrics, and periodic imaging when appropriate.
• Communicate with case managers and employers to align activity modifications.

By integrating orthobiologics, chiropractic, rehab, and medical oversight, we reduce time to safe function and minimize the risk of recurrence.

Putting It All Together: A Practical Care Pathway

For a patient with mild knee OA and focal patellar tendinopathy:

• Step 1: Evaluate systemic factors with Dr. Cardenas (uric acid, lipids including Lp(a) if indicated, vitamin D, thyroid function). Begin anti-inflammatory nutrition, sleep support, and swelling control.
• Step 2: Ultrasound to define tendon pathology; MRI if needed for subchondral assessment.
• Step 3: PRP injection targeted to the partial tendon tear; activity protection for 3–7 days; no NSAIDs.
• Step 4: Isometric analgesia → progressive eccentrics/HSR; hip abductor and core strengthening; gait retraining.
• Step 5: Reassess at 6 and 12 weeks. If <60% improvement at 12 weeks, consider joint-directed PRP or adjunctive biologic, refine rehab loading, or address newly identified systemic barriers.

For a partial-thickness rotator cuff tear:

• Step 1: Ultrasound mapping; MRI review for edema and tear characterization.
• Step 2: Ultrasound-guided PRP to interstitial tear with adjunct to inflamed tissue planes if warranted; protect against provocative overhead loads early.
• Step 3: Scapular stabilization, posterior capsule mobility, progressive rotator cuff conditioning, kinetic chain integration.
• Step 4: Monitor function and pain; adapt plan based on cable adjacency and biceps-related mechanics.

Why This Integrated Model Works

• It is evidence-aligned: We select cases supported by current studies and apply biologics where continuity and biology favor healing.
• It is systems-aware: Internal medicine oversight ensures comorbidities and biomarkers are managed to enhance tissue repair.
• It is biomechanics-first: Chiropractic and rehab interventions shape forces to match the tissue’s healing capacity and phase.
• It is patient-centered: Clear timelines, milestones, and decision points structure a predictable journey for patients.

Closing Perspective

Our collaboration at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas—uniting my integrative chiropractic and functional medicine practice with Dr. Maria Guadalupe Cardenas’ internal medicine leadership—reflects where musculoskeletal care is heading: precision, personalization, and partnership. By aligning biologics with mechanics and metabolism, we can help patients move beyond pain toward resilient, confident function.

---

References

• [Platelet-rich plasma for osteoarthritis: A systematic review and meta-analysis] (2021). American Journal of Sports Medicine. https://doi.org/10.1177/03635465211026821
• [Biologic injections for rotator cuff pathology: Evidence synthesis and treatment considerations] (2022). Journal of Shoulder and Elbow Surgery. https://doi.org/10.1016/j.jse.2022.03.015
• [PRP in chronic tendinopathy: Mechanisms and clinical outcomes] (2020). Sports Medicine. https://doi.org/10.1007/s40279-019-01206-w
• [Machine learning models to predict PRP response in knee osteoarthritis] (2025). Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.01.005
• [Subchondral bone marrow lesions and pain in knee osteoarthritis: Pathophysiology and treatment implications] (2019). Nature Reviews Rheumatology. https://doi.org/10.1038/s41584-019-0264-1
• [The rotator cable: Biomechanics and clinical implications] (2018). Journal of Bone and Joint Surgery. https://doi.org/10.2106/JBJS.17.00980
• [Microfragmented adipose tissue in moderate knee osteoarthritis: Outcomes and safety] (2021). Arthroscopy. https://doi.org/10.1016/j.arthro.2020.12.123
• [Percutaneous ultrasonic tenotomy and lavage for calcific tendinitis] (2020). Skeletal Radiology. https://doi.org/10.1007/s00256-019-03272-0
• [Neuromodulatory effects of spinal manipulation on pain processing] (2017). Pain. https://doi.org/10.1097/j.pain.0000000000000807
• [AAOS appropriate use criteria for osteoarthritis of the knee] (2022). Journal of the American Academy of Orthopaedic Surgeons. https://doi.org/10.5435/JAAOS-D-21-01045